These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
194 related items for PubMed ID: 7828098
1. Safety and effectiveness of the new inactivated hepatitis A virus vaccine. Furesz J, Scheifele DW, Palkonyay L. CMAJ; 1995 Feb 01; 152(3):343-8. PubMed ID: 7828098 [Abstract] [Full Text] [Related]
2. Evaluation of inactivated hepatitis A vaccine in Canadians 40 years of age or more. Scheifele DW, Bjornson GJ. CMAJ; 1993 Feb 15; 148(4):551-5. PubMed ID: 8431816 [Abstract] [Full Text] [Related]
4. [Evaluation of immunogenicity and safety in healthy adults of an inactivated anti-hepatitis A vaccine]. Gil A, González A, Dal-Ré, Aguilar L, Malo C, del Rey J. Med Clin (Barc); 1994 May 28; 102(20):769-71. PubMed ID: 8041214 [Abstract] [Full Text] [Related]
5. Clinical trial to evaluate immunogenicity and safety of inactivated hepatitis A vaccination starting at 2-month-old children. Kanra G, Yalçin SS, Ceyhan M, Yurdakök K. Turk J Pediatr; 2000 May 28; 42(2):105-8. PubMed ID: 10936974 [Abstract] [Full Text] [Related]
6. Immunogenicity and safety of an inactivated hepatitis A vaccine in Taiwanese adults and children. Lee CY, Huang LM, Lee PI, Chiu HH, Dumas R, Milcamps B, Lin W. Southeast Asian J Trop Med Public Health; 2000 Mar 28; 31(1):29-36. PubMed ID: 11023061 [Abstract] [Full Text] [Related]
7. Immunogenicity and safety of a new inactivated hepatitis A vaccine in Thai young adults. Vimolket T, Theamboonlers A, Dumas R, Milcamps B, Forrat R, Poovorawan Y. Southeast Asian J Trop Med Public Health; 1998 Dec 28; 29(4):779-85. PubMed ID: 10772564 [Abstract] [Full Text] [Related]
9. Immunogenicity and safety of an inactivated hepatitis A vaccine amongst Singaporeans. Guan R, Ng HS, Fock KM, Ho KY, Yap I, Kang JY, Chow WC, Chew CN, Ng C, Teo CJ. Southeast Asian J Trop Med Public Health; 1995 Jun 28; 26(2):268-71. PubMed ID: 8629058 [Abstract] [Full Text] [Related]
11. Immunogenicity and reactogenicity of an inactivated hepatitis A vaccine in Indian adults. Das K, Jain A, Gupta RK, Kar P. Natl Med J India; 1999 Jun 28; 12(6):268-9. PubMed ID: 10732428 [Abstract] [Full Text] [Related]
13. Immunogenicity and safety of three consecutive lots of a new preservative-free inactivated hepatitis A vaccine (Healive): a double-blind, randomized and controlled trial. Jiang WP, Chen JT, Wang X, Wang YL, Liu Y, Chen WY, Xu WG, Qiu YZ, Yin WD. Vaccine; 2008 Apr 24; 26(18):2297-301. PubMed ID: 18395305 [Abstract] [Full Text] [Related]
19. Immunogenicity and safety of an inactivated hepatitis A vaccine administered concomitantly with diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines to children less than 2 years of age. Nolan T, Bernstein H, Blatter MM, Bromberg K, Guerra F, Kennedy W, Pichichero M, Senders SD, Trofa A, Collard A, Sullivan DC, Descamps D. Pediatrics; 2006 Sep 24; 118(3):e602-9. PubMed ID: 16950952 [Abstract] [Full Text] [Related]
20. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. Werzberger A, Mensch B, Kuter B, Brown L, Lewis J, Sitrin R, Miller W, Shouval D, Wiens B, Calandra G. N Engl J Med; 1992 Aug 13; 327(7):453-7. PubMed ID: 1320740 [Abstract] [Full Text] [Related] Page: [Next] [New Search]